STADA Arzneimittel AG | STADA
[/] Company Products Stories Sustainability Investors Media Career About STADA Management Our Corporate Culture STADA worldwide Company history Compliance About STADA STADA worldwide Consumer Healthcare Products Specialty Pharmaceuticals Generics Partnerships Quality at STADA Adverse drug reaction report Consumer Healthcare Products Specialty Pharmaceuticals Sustainability Report Supply Chain Act Sustainability Report Supply Chain Act At a Glance Stock Financial Publications Calendar General Meeting Corporate Governance IR Contact STADA Financial Calendar Financial Publications Newsroom Press Releases Press Photos STADA Health Reports Social Media Media Contact Press Releases STADA Health Report 2024 Purpose, Vision, and Values Your Growth Journey Your Benefits Search all jobs Explore STADA en Deutsch (DE) 123 Company Products Stories Sustainability Investors Media Career English | Deutsch Select your country Back Websites worldwide Australia STADA Pharmaceuticals Australia Pty. Ltd Austria STADA Arzneimittel GmbH Belarus STADA Belarus Belgium EG nv Bosnia-Herzegovina Hemofarm Banja Luka d.o.o Bulgaria Stada Bulgaria China STADA Pharmaceuticals (Beijing) Ltd Croatia STADA d.o.o. Czech Republic STADA PHARMA CZ, s.r.o. Walmark a.s. Denmark STADA NORDIC ApS France EG LABO - Laboratoires EuroGenerics Germany ALIUD PHARMA® GmbH STADA Consumer Health Deutschland GmbH STADAPHARM GmbH Hungary STADA Hungary Ireland Clonmel Healthcare Limited Italy EG S.p.A. Montenegro Hemomont d.o.o. Netherlands Centrafarm B.V. Healthypharm B.V. Poland STADA Poland Sp. z o.o. Portugal STADA, LDA Romania STADA M&D, Romania Saudi Arabia STADA MENA DWC LLC Serbia Hemofarm A.D. Slovakia STADA PHARMA Slovakia s.r.o Slovenia STADA d.o.o. Spain LABORATORIO STADA, SLU Switzerland Spirig HealthCare AG The Phillippines STADA Philippines United Arab Emirates STADA MENA DWC LLC United Kingdom Natures Aid Ltd Thornton & Ross Ltd. Britannia Pharmaceuticals Ltd Vietnam Pymepharco JSC STADA Vietnam Back Company About STADA Management Our Corporate Culture STADA worldwide Company history Compliance Back Products Consumer Healthcare Products Specialty Pharmaceuticals Generics Partnerships Quality at STADA Adverse drug reaction report Back Sustainability Sustainability Report Supply Chain Act Back Investors At a Glance Stock Financial Publications Calendar General Meeting Corporate Governance IR Contact Back Media Newsroom Press Releases Press Photos STADA Health Reports Social Media Media Contact Back Career Purpose, Vision, and Values Your Growth Journey Your Benefits 123 Select your country Australia Austria Belarus Belgium Bosnia-Herzegovina Bulgaria China Croatia Czech Republic Denmark France Germany Hungary Ireland Italy Montenegro Netherlands Poland Portugal Romania Saudi Arabia Serbia Slovakia Slovenia Spain Switzerland The Phillippines United Arab Emirates United Kingdom Vietnam Websites worldwide Select a country to go to the website of the respective STADA sales company. Australia (1) STADA Pharmaceuticals Australia Pty. Ltd Austria (1) STADA Arzneimittel GmbH Belarus (1) STADA Belarus Belgium (1) EG nv Bosnia-Herzegovina (1) Hemofarm Banja Luka d.o.o Bulgaria (1) Stada Bulgaria China (1) STADA Pharmaceuticals (Beijing) Ltd Croatia (1) STADA d.o.o. Czech Republic (2) STADA PHARMA CZ, s.r.o. Walmark a.s. Denmark (1) STADA NORDIC ApS France (1) EG LABO - Laboratoires EuroGenerics Germany (3) ALIUD PHARMA® GmbH STADA Consumer Health Deutschland GmbH STADAPHARM GmbH Hungary (1) STADA Hungary Ireland (1) Clonmel Healthcare Limited Italy (1) EG S.p.A. Montenegro (1) Hemomont d.o.o. Netherlands (2) Centrafarm B.V. Healthypharm B.V. Poland (1) STADA Poland Sp. z o.o. Portugal (1) STADA, LDA Romania (1) STADA M&D, Romania Saudi Arabia (1) STADA MENA DWC LLC Serbia (1) Hemofarm A.D. Slovakia (1) STADA PHARMA Slovakia s.r.o Slovenia (1) STADA d.o.o. Spain (1) LABORATORIO STADA, SLU Switzerland (1) Spirig HealthCare AG The Phillippines (1) STADA Philippines United Arab Emirates (1) STADA MENA DWC LLC United Kingdom (3) Natures Aid Ltd Thornton & Ross Ltd. Britannia Pharmaceuticals Ltd Vietnam (2) Pymepharco JSC STADA Vietnam Strong growth journey in H1 2024 Read more Launch of ustekinumab biosimilar in Europe Read more Satisfaction with healthcare systems continues to decline Read more The STADA Health Report 2024 Read more 3rd Sustainability Report Outstanding results showcasing our exceptional journey toward sustainability Read more Explore STADA Sustainability For responsible production and consumption, STADA contributes to SDG 12 by finding innovative ways to be more sustainable through the entire lifecycle of its products. Diversity & Inclusion Our culture thrives on empowering our people to bring forward their unique and diverse experiences. Thought leadership article by Simone Berger, CPO. Trusted Partner Central to STADA's commitment to caring for people's health through consumer healthcare products, generics and specialty medicines are close partnerships to improve health globally. Culture Our employees drive STADA’s growth culture. This is energized by the actions of our people every day to bring health to society as One STADA team. Read the #CountlessReason story of Catalina Medaru Patient Health & Safety STADA promotes access to affordable, effective and high-quality medicines. We are committed to improving the quality of life of patients. Three-pillar Strategy The company focuses on consumer healthcare products, generics and speciality medicines. Your opportunity for success with STADA We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment. Careers at STADA Growth mindset: Our people are our ambassadors Follow us on LinkedIn Meet Andreas Jaworski, Head of the AS&T Lab at STADA Group . By Delia Heeger-Heß, Senior Manager Talent Acquisition at STADA Group I had great fun joining the ANZ Commercial Team during their cycle meeting this week. By Gina James, Culture and People Business Partner at STADA Group Growth Mindset is all about stepping out of your comfort zone and gaining new perspectives . By Simone Berger, Chief People Officer / Executive Board Member at STADA Group Empowering Partnerships: STADA and New Pharma are Shaping the Future for Growth. By Stéphane Jacqmin, EVP Emerging Markets at STADA Group Delia Heeger-Heß on LinkedIn Senior Manager Talent Acquisition at STADA Group 14 August 2024 Meet Andreas Jaworski, Head of the AS&T Lab at STADA Group . Find out how a cold has affected his professional life, why he likes working at STADA and how he likes to spend his free time. View on LinkedIn Gina James on LinkedIn Culture and People Business Partner at STADA Group 8 August 2024 I had great fun joining the ANZ Commercial Team during their cycle meeting this week. Well done Anne Cremin , Linda C. and Lisa Beggs on a successfully executed program👏 Thanks for allocating time during your busy agenda to get silly with me while we reiforced our # GrowthMindset learnings! # LearningFromFailure # OneSTADA # GrowthMindset H # ContinuousImprovement STADA Emerging Markets Jocelyn Oliver Elise Tune Tess Lindh Craig Trevethan # RaymondBaissary # SusieWalding # KylieNoeth View on LinkedIn Simone Berger on LinkedIn Chief People Officer / Executive Board Member at STADA Group 12 August 2024 Growth Mindset is all about stepping out of your comfort zone and gaining new perspectives. And what better way to foster this than to take on a new role in another country, as Mark, Aleksa and Fatimah recently did! Their stories show how # InternationalMobility strengthens STADA's values of One STADA and Entrepreneurship: As different perspectives and best practices travel across borders, cross-country collaboration and continuous learning become an essential part of STADA's growth culture. Read more about their stories in our blog: https://lnkd.in/eJjZSXW6 # OneSTADA # GrowthMindsetters # BeAGrowthMindsetter # GrowthCulture View on LinkedIn Stéphane Jacqmin on LinkedIn EVP Emerging Markets at STADA Group 12 August 2024 The pharmaceutical company STADA is expanding its consumer healthcare business in the MENA region with the acquisition of FITO™ from LEO Pharma . The medical device is based on the wheat extract Rigenase ( Farmaceutici Damor S.p.A. , Italy) and is indicated for the dermatological treatment of first- and second-degree burns, ulcers, wounds and abrasions. The herbal origin has a high safety profile and forms a protective barrier against the external environment. The acquisition includes the takeover of the existing business in the markets of Egypt, Kuwait, Oman, Saudi Arabia and the United Arab Emirates. Other key markets are Algeria, Bahrain, Iraq, Kenya, Lebanon, Libya, Mauritius, Morocco, Pakistan, Palestine, Qatar, Tunisia and Yemen. STADA EVP Stéphane Jacqmin Emerging Markets: "We look forward to leveraging our local marketing and sales strength to develop the full potential of this strong brand in the many markets of the MENA region. This will strengthen STADA's role as the partner of choice in consumer healthcare and support our growth in the region.” In addition to this acquisition, STADA MENA has also entered into a supply and distribution agreement with Farmaceutici DAMOR S.p.A, Italy. # Dermatology # Rigenase # ConsumerHealthcare # Acquisition # LEOPharma # FITO # STADA STADA Group STADA Emerging Markets View on LinkedIn STADA Voices Miguel Pagan Fernandez Frank Staud Volker Sydow Stéphane Jacqmin Dr. Christoph Dengler Christos Gallis Sustainability Stories Latest news 26/07/2024 European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine Read more 22/07/2024 STADA launches ustekinumab biosimilar in Europe Read more 24/06/2024 STADA Health Report 2024: Satisfaction with healthcare systems continues to decline Read more 11/06/2024 Alvotech and STADA add to strategic alliance through denosumab partnership Read more 28/05/2024 Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, EU and UK Read more 21/05/2024 STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey Read more 10/05/2024 Xbrane, STADA partner with Valorum Biologics to commercialize ranibizumab biosimilar candidate in the US Read more 14/03/2024 STADA continues with double-digit sales and profit growth in 2023 Read more 10/01/2024 STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara Read more 09/01/2024 Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner Read more Read our news Consumer Healthcare products STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range. View our brands Improving access to life-changing treatments for patients worldwide Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases. STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions. Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”. Specialty Pharmaceuticals Affordable generics have been the backbone of STADA since 1895 As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales. Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure. Generics Our purpose is ‘Caring for People’s Health as a Trusted Partner’ At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business – and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty. Our purpose Products Nizoral® Nizoral® Nizoral® is a medical treatment against dandruff. Nizoral® Grippostad® Grippostad® Grippostad® C is a medicine against flu infections and colds. Grippostad® Lunestil® Lunestil® Lunestil® duo-capsule technology offer innovative ways to get a good night’s sleep. Lunestil® Immunology Nephrology Neurology Company About us Products Investors Media Career STADA Worldwide Get in Touch Contact info@stada.de +49 6101 603-0 Compliance Reporting Portal ⧉ FOLLOW US Conditions of Use Privacy Policy Imprint Cookie settings Progenerika © Copyright STADA Arzneimittel AG 2024